Niki BioSolutions NIKI
NASDAQ NIKI
$4.74 -0.07 (-1.46%)
As of: Oct 2, 2026 · 11:06 AM EDT

Niki BioSolutions (NIKI) Non Operating Income (2024 - 2025)

Updated

Niki BioSolutions' Non Operating Income came in at $351,481 for FY2025.

Analysis

Niki BioSolutions (NIKI) Non Operating Income (2024 - 2025) Analysis & Trends

Going back to FY2017, Niki BioSolutions' Non Operating Income data covers 9 years.

  • Non Operating Income carries a five-year compound annual growth rate of -57.4% (FY2020 to FY2025).
  • The five-year range for annual Non Operating Income is -$7.91 million (FY2021) to $6.38 million (FY2023).
  • Per Business Quant, earlier years put Non Operating Income at -$217,196 in FY2024, $6.38 million in FY2023 (+6.7%), $5.98 million in FY2022 and -$7.91 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Niki BioSolutions 2.67 Mn 2.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 114,997.00
Nov 30, 2024 -18,673.00
Aug 31, 2024 -20,166.00
API Access

Niki BioSolutions Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=NIKI&period=max&api_key=YOUR_API_KEY